CurtisAndrewLachowiezMD

PubMed

• Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia.
  Daniel J Chandra, Curtis A Lachowiez, Sanam Loghavi> ;Blood Reviews. 2024 Mar 1
• 1 citations
  Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
  Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan M Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas J Short, Koji Sasak...> ;Blood Cancer Journal. 2023 Sep 21
• 3 citations
  Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.
  Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Sha...> ;Blood Cancer Discovery. 2023 Nov 1
• Anthracycline induced left ventricular dysfunction in AML: A focus on the molecularly defined future of cardio-oncology.
  Daniel J Chandra, Curtis A Lachowiez> ;Leukemia Research. 2023 Oct 1
• 2 citations
  Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia.
  Emmanuella Oyogoa, Elie Traer, Jeffrey Tyner, Curtis Lachowiez> ;Cancers. 2023 Jul 12
• 36 citations
  A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
  Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Y Duose, Rebe...> ;Blood Cancer Discovery. 2023 Jul 5
• 4 citations
  Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance.
  Curtis A Lachowiez, Courtney D DiNardo, Sanam Loghavi> ;Cancers. 2023 Mar 6
• 23 citations
  Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.
  Curtis A Lachowiez, Nicola Long, Jennifer Saultz, Arpita Gandhi, Laura F Newell, Brandon Hayes-Lattin, Richard T Maziarz, Jessica Leonard, Daniel Bottomly, Shannon McW...> ;Blood Advances. 2023 May 9
• 11 citations
  Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment.
  Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, Elias Jabbour, Gautam Borthakur, Naval Daver, Ghayas Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guili...> ;American Journal of Hematology. 2022 Nov 1
• 19 citations
  Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome.
  Courtney D DiNardo, Sangeetha Venugopal, Curtis Lachowiez, Koichi Takahashi, Sanam Loghavi, Guillermo Montalban-Bravo, Xuemei Wang, Hetty Carraway, Mikkael Sekeres, Am...> ;Blood Advances. 2023 Jun 13
• 31 citations
  Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
  Courtney D DiNardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Kadia, Naval Daver, Lianchun Xiao, Maria Adeoti, Nicholas J Short, Koji Sasaki, Sa A Wan...> ;American Journal of Hematology. 2022 Aug 1
• 23 citations
  Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.
  Curtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, Elias Jabbour, Gautam Borthakur, Naval Daver, Sanam Loghavi, Ken Furudate, Lianchun Xiao, Sherry Pierce, Nicho...> ;The Lancet. Haematology. 2022 May 1
• 2 citations
  Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia: An Evolving Treatment Landscape.
  Curtis Lachowiez, Courtney D DiNardo, Etyan Stein> ;Cancer Journal. 2022 Jan 24
• 10 citations
  Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.
  Curtis A Lachowiez, Himachandana Atluri, Courtney D DiNardo> ;Therapeutic Advances in Hematology. 2022 Jan 1
• 137 citations
  Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia
  Courtney D. DiNardo, Curtis Lachowiez, Koichi Takahashi, Sanam Loghavi, Lianchun Xiao, Tapan M. Kadia, Naval Daver, Maria Adeoti, Nicholas J. Short, Koji Sasaki, Sa Wa...> ;Journal of Clinical Oncology. 2021 May 27
• 31 citations
  Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
  Curtis Lachowiez, Sanam Loghavi, Ken Furudate, Guillermo Montalban-Bravo, Abhishek Maiti, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki,...> ;Blood Advances. 2021 Apr 27
• 1 citations
  Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
  Soun Khountham, Polina Shindiapina, Xiaokui Mo, Curtis Lachowiez, Tracy Wiczer, Luay Mousa, Kerry A. Rogers, Leslie A. Andritsos, Jennifer A. Woyach, John C. Byrd, Ste...> ;Leukemia & Lymphoma. 2021 Feb 23
• 1 citations
  Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.
  Effrosyni Apostolidou, Curtis Lachowiez, Harinder S. Juneja, Wei Qiao, Onyebuchi Ononogbu, Courtney Nicole Miller-Chism, Mark M. Udden, Hilary Y. Ma, Martha P. Mims> ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Sep 1
• 6 citations
  Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations
  Curtis Lachowiez, Sarah A. Bannon, Sanam Loghavi, Feng Wang, Rashmi Kanagal-Shamanna, Rohtesh S. Mehta, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Farhad Ravandi...> ;American Journal of Hematology. 2020 Aug 17
• 98 citations
  Outcomes of older patients with NPM1-mutated AML: current treatments and the promise of venetoclax-based regimens.
  Curtis Lachowiez, Sanam Loghavi, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Kiran Naqvi, Yesid Alvarado, Musa Yilmaz, Nicholas J. Short, Maro Oha...> ;Blood Advances. 2020 Apr 14
• 27 citations
  Venetoclax in acute myeloid leukemia - current and future directions.
  Curtis Lachowiez, Courtney D. DiNardo, Marina Konopleva> ;Leukemia & Lymphoma. 2020 Feb 7
• 31 citations
  Acute Myeloid Leukemia: from Mutation Profiling to Treatment Decisions
  Courtney D. DiNardo, Curtis Lachowiez> ;Current Hematologic Malignancy Reports. 2019 Oct 1
• Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy.
  Curtis Lachowiez, Matthew R. Kearney, Gabrielle Meyers, Richard T. Maziarz, Rachel J. Cook> ;Leukemia & Lymphoma. 2019 May 6
• 5 citations
  Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
  Curtis Lachowiez, Rachel J. Cook, Brandon Hayes-Lattin, Richard T. Maziarz, Uma Borate, Elie Traer, Jessica Leonard, Laura F. Newell, Kim Hien T. Dao, Gabrielle Meyers> ;Hematology/oncology and Stem Cell Therapy. 2019 Jun 1
• 2 citations
  Exaggerated arthropod assault: Eosinophilic dermatosis in a patient with small lymphocytic lymphoma
  Curtis Lachowiez, Kevin P. White, Stephen E. Spurgeon> ;Clinical Case Reports. 2018 Jul 17
• Join now to see all